The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer – a study protocol

Peer Review reports

Original Submission
8 Apr 2021	Submitted	Original manuscript
29 Apr 2021	Reviewed	Reviewer Report - Haito Pan
5 Aug 2021	Author responded	Author comments - Stephan Ursprung
Resubmission - Version 2
5 Aug 2021	Submitted	Manuscript version 2
29 Oct 2021	Reviewed	Reviewer Report - Haito Pan
3 Nov 2021	Author responded	Author comments - Stephan Ursprung
Resubmission - Version 3
3 Nov 2021	Submitted	Manuscript version 3
Publishing
4 Nov 2021	Editorially accepted
18 Nov 2021	Article published	10.1186/s12885-021-08965-4

Back to article page